Bioavailability
Bioavailability studies play a critical role in evaluating how drugs are absorbed, distributed, metabolized, and eliminated within the body. CenExel supports sponsors with high-quality bioavailability research, delivering reliable pharmacokinetic data that informs drug development, formulation optimization, and regulatory submissions.




Studies Conducted
Trial Participants
Active Sites
Leading Acute Pain Clinical Research
CenExel provides comprehensive bioavailability research services designed to support early- and late-stage drug development programs. Our experienced investigators and clinical research teams conduct studies that evaluate drug absorption, systemic exposure, and formulation performance across diverse patient populations.
We leverage advanced clinical and analytical capabilities to generate precise pharmacokinetic data, helping sponsors meet regulatory requirements while accelerating development timelines.
From first-in-human studies to comparative bioavailability assessments, CenExel delivers scientific rigor and operational excellence throughout every phase of research.
Acute Pain Conditions We Research
Our acute bioavailability research sites support a broad spectrum of post-operative and procedure-related pain conditions.
Absolute Bioavailability Studies
Relative Bioavailability Studies
Food Effect Studies
Bioequivalence Studies
Formulation Comparison Studies
Single-Dose Studies
Multiple-Dose Studies
Drug-Drug Interaction Studies
Modified Release Formulation Studies
Post-Cesarean Pain
Why Sponsors Choose CenExel for Bioavailability
Our specialized teams deliver reliable pharmacokinetic data, streamlined operations, and scientific expertise that help sponsors make informed development decisions.
01
Experienced Clinical Pharmacology Teams
Dedicated experts with extensive experience in bioavailability and PK study execution.
02
Advanced Data Collection
Accurate sample collection, processing, and analysis supporting high-quality study outcomes.
03
Efficient Study Execution
Rapid startup timelines and operational excellence to keep development programs on schedule.
04
Regulatory-Ready Results
Comprehensive data generation supporting FDA and global regulatory requirements.
Supported Trial Phases
We support bioavailability studies across early and late-stage development programs, ensuring accurate pharmacokinetic evaluation throughout the product lifecycle.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our research teams provide expertise in first-in-human studies, formulation bridging studies, food-effect evaluations, and post-marketing pharmacokinetic assessments.
Bioavailability Task Force
CenExel's Bioavailability Task Force brings together clinical pharmacologists, principal investigators, and operational experts with extensive experience in bioavailability and pharmacokinetic research.
Active Sites
15 Sites
Also in Pain & Inflammation
